EMED
Electromedical Technologies, Inc.
Price Chart
Latest Quote
$0.00
+0.00 (+0.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 6,828,002 |
Stock Information
| Shares Outstanding | 3.73B |
| Total Debt | $1.66M |
| Cash Equivalents | $35K |
| Revenue | $922K |
| Net Income | $-1.68M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $373K |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.48M |
| Sales | $922K |
| Income | $-1.68M |
| Book/sh | $-0.01 |
| Cash/sh | $0.00 |
| Employees | 6 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.07 |
Returns & Margins
| ROA | -88.83% |
| Gross Margin | 75.08% |
| Operating Margin | -896.01% |
| Profit Margin | -182.03% |
Ownership
| Insider Ownership | 0.48% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.40 |
| P/B | -0.01 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | 33.33 |
| ATR | 0.0001 |
| Shares Float | 851.22M |
| Volatility | 1.10 |
| Rel Volume | 0.68 |
Performance History
| Week | -33.33% |
| Month | -33.33% |
| Quarter | +0.00% |
| 6 Months | -50.00% |
| YTD | -50.00% |
| Year | -50.00% |
| 3 Years | -91.67% |
| 5 Years | -99.88% |
| 10 Years | -99.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.00 | 8,730,000 |
| 2026-06-17 | $0.00 | 7,661,809 |
| 2026-06-16 | $0.00 | 22,521,824 |
| 2026-06-15 | $0.00 | 17,500,300 |
| 2026-06-12 | $0.00 | 25,364,285 |
| 2026-06-11 | $0.00 | 0 |
| 2026-06-10 | $0.00 | 1,500,100 |
| 2026-06-09 | $0.00 | 6,996,618 |
| 2026-06-08 | $0.00 | 25,700 |
| 2026-06-05 | $0.00 | 351,011 |
| 2026-06-04 | $0.00 | 57,614 |
| 2026-06-03 | $0.00 | 1,001,011 |
| 2026-06-02 | $0.00 | 5,313,600 |
| 2026-06-01 | $0.00 | 612,012 |
| 2026-05-29 | $0.00 | 1,023,100 |
| 2026-05-28 | $0.00 | 13,389,100 |
| 2026-05-27 | $0.00 | 1,553,961 |
| 2026-05-26 | $0.00 | 35,410,659 |
| 2026-05-22 | $0.00 | 105,691,199 |
| 2026-05-21 | $0.00 | 196,000 |
| 2026-05-20 | $0.00 | 24,513,144 |
| 2026-05-19 | $0.00 | 29,867,900 |
About Electromedical Technologies, Inc.
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. It also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. The company serves chiropractors, physiotherapists, pain management doctors and clinicians, natural medicine doctors, sports medicine doctors, and athletic trainers. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona.
đ° Latest News
No news articles available at the moment. Check back later for updates on EMED.
Period:
Loading...
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $303,303 | $261,203 | $199,234 |
| Cost Of Revenue | $303,303 | $261,203 | $199,234 |
| Total Revenue | $1,348,808 | $1,149,844 | $907,362 |
| Operating Revenue | $1,348,808 | $1,149,844 | $907,362 |
| Expenses | |||
| Interest Expense | $893,155 | $791,072 | $3,313,852 |
| Total Expenses | $3,413,749 | $2,753,372 | $4,707,625 |
| Other Income Expense | $316,850 | $-1,073,900 | $-1,366,034 |
| Other Non Operating Income Expenses | $-409,000 | - | $-432 |
| Net Non Operating Interest Income Expense | $-893,155 | $-791,072 | $-3,313,852 |
| Interest Expense Non Operating | $893,155 | $791,072 | $3,313,852 |
| Operating Expense | $3,110,446 | $2,492,169 | $4,508,391 |
| Other Operating Expenses | $435,979 | $244,606 | $164,683 |
| Selling And Marketing Expense | $191,689 | $251,133 | $299,872 |
| General And Administrative Expense | $2,251,344 | $1,904,131 | $3,828,516 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-2,641,246 | $-3,468,500 | $-8,480,149 |
| Net Interest Income | $-893,155 | $-791,072 | $-3,313,852 |
| Normalized Income | $-3,367,096 | $-2,394,600 | $-7,114,547 |
| Net Income From Continuing And Discontinued Operation | $-2,641,246 | $-3,468,500 | $-8,480,149 |
| Total Operating Income As Reported | $-2,064,941 | $-1,603,528 | $-3,800,263 |
| Net Income Common Stockholders | $-2,644,707 | $-3,576,388 | $-12,250,980 |
| Net Income | $-2,641,246 | $-3,468,500 | $-8,480,149 |
| Net Income Including Noncontrolling Interests | $-2,641,246 | $-3,468,500 | $-8,480,149 |
| Net Income Continuous Operations | $-2,641,246 | $-3,468,500 | $-8,480,149 |
| Pretax Income | $-2,641,246 | $-3,468,500 | $-8,480,149 |
| Special Income Charges | $1,202,057 | $-1,073,900 | $50,083 |
| Operating Income | $-2,064,941 | $-1,603,528 | $-3,800,263 |
| Gross Profit | $1,045,505 | $888,641 | $708,128 |
| Per Share | |||
| Diluted EPS | $-0.01 | $-0.03 | $-0.24 |
| Basic EPS | $-0.01 | $-0.03 | $-0.24 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,447,736 | $-1,581,653 | $-3,778,820 |
| Total Unusual Items | $725,850 | $-1,073,900 | $-1,365,602 |
| Total Unusual Items Excluding Goodwill | $725,850 | $-1,073,900 | $-1,365,602 |
| Reconciled Depreciation | $26,205 | $21,875 | $21,875 |
| EBITDA (Bullshit earnings) | $-1,721,886 | $-2,655,553 | $-5,144,422 |
| EBIT | $-1,748,091 | $-2,677,428 | $-5,166,297 |
| Diluted Average Shares | $377,216,319 | $133,596,295 | $50,992,414 |
| Basic Average Shares | $377,216,319 | $133,596,295 | $50,992,414 |
| Diluted NI Availto Com Stockholders | $-2,644,707 | $-3,576,388 | $-12,250,980 |
| Otherunder Preferred Stock Dividend | $3,461 | $107,888 | $3,770,831 |
| Gain On Sale Of Ppe | $1,193,676 | $0 | - |
| Other Special Charges | $-8,381 | $1,073,900 | $-50,083 |
| Gain On Sale Of Security | $-476,207 | - | $-1,415,685 |
| Research And Development | $231,434 | $92,299 | $215,320 |
| Selling General And Administration | $2,443,033 | $2,155,264 | $4,128,388 |
| Other Gand A | $799,400 | $940,954 | $1,386,758 |
| Salaries And Wages | $1,451,944 | $963,177 | $2,441,758 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-2,872,787 | $-2,220,845 | $-722,503 |
| Total Assets | $748,383 | $1,353,271 | $1,402,111 |
| Total Non Current Assets | $299,198 | $705,469 | $727,344 |
| Current Assets | $449,185 | $647,802 | $674,767 |
| Other Current Assets | $288,565 | $207,872 | $38,002 |
| Inventory | $68,517 | $62,061 | $218,510 |
| Receivables | $4,399 | $9,444 | $35,085 |
| Accounts Receivable | $4,399 | $9,444 | $35,085 |
| Allowance For Doubtful Accounts Receivable | $-1,845 | $-1,000 | $-1,000 |
| Gross Accounts Receivable | $6,244 | $10,444 | $36,085 |
| Cash Cash Equivalents And Short Term Investments | $87,704 | $368,425 | $383,170 |
| Cash And Cash Equivalents | $87,704 | $368,425 | $383,170 |
| Cash Financial | $87,704 | $368,425 | - |
| Prepaid Assets | - | - | $38,002 |
| Debt | |||
| Net Debt | $1,455,897 | $1,608,009 | $1,189,172 |
| Total Debt | $1,698,546 | $1,976,434 | $1,572,342 |
| Long Term Debt And Capital Lease Obligation | $256,200 | $639,707 | $673,278 |
| Long Term Debt | $150,000 | $639,707 | $673,278 |
| Current Debt And Capital Lease Obligation | $1,442,346 | $1,336,727 | $899,064 |
| Current Debt | $1,393,601 | $1,336,727 | $899,064 |
| Other Current Borrowings | $1,393,601 | $1,336,727 | $841,189 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $3,621,170 | $3,574,116 | $2,124,614 |
| Total Non Current Liabilities Net Minority Interest | $264,616 | $649,941 | $682,445 |
| Other Non Current Liabilities | $8,416 | $10,234 | $9,167 |
| Current Liabilities | $3,356,554 | $2,924,175 | $1,442,169 |
| Other Current Liabilities | $532,334 | - | - |
| Current Deferred Liabilities | $197,325 | $217,588 | $0 |
| Payables And Accrued Expenses | $1,184,549 | $1,369,860 | $543,105 |
| Payables | $267,578 | $304,377 | $226,068 |
| Other Payable | $28,097 | $37,633 | $11,283 |
| Accounts Payable | $239,481 | $266,744 | $214,785 |
| Current Notes Payable | - | $0 | $57,875 |
| Equity | |||
| Common Stock Equity | $-3,637,787 | $-2,585,845 | $-1,077,503 |
| Preferred Stock Equity | $765,000 | $365,000 | $355,000 |
| Total Equity Gross Minority Interest | $-2,872,787 | $-2,220,845 | $-722,503 |
| Stockholders Equity | $-2,872,787 | $-2,220,845 | $-722,503 |
| Retained Earnings | $-27,469,748 | $-24,825,041 | $-21,882,712 |
| Other | |||
| Ordinary Shares Number | $463,286,208 | $189,784,529 | $87,725,842 |
| Share Issued | $463,286,208 | $189,784,529 | $87,725,842 |
| Tangible Book Value | $-3,637,787 | $-2,585,845 | $-1,077,503 |
| Invested Capital | $-2,094,186 | $-609,411 | $494,839 |
| Working Capital | $-2,907,369 | $-2,276,373 | $-767,402 |
| Capital Lease Obligations | $154,945 | $0 | - |
| Total Capitalization | $-2,722,787 | $-1,581,138 | $-49,225 |
| Additional Paid In Capital | $23,827,330 | $22,237,300 | $20,804,333 |
| Capital Stock | $769,631 | $366,896 | $355,876 |
| Common Stock | $4,631 | $1,896 | $876 |
| Preferred Stock | $765,000 | $365,000 | $355,000 |
| Long Term Capital Lease Obligation | $106,200 | $0 | - |
| Current Deferred Revenue | $197,325 | $217,588 | $0 |
| Current Capital Lease Obligation | $48,745 | $0 | - |
| Current Accrued Expenses | $916,971 | $1,065,483 | $317,037 |
| Net PPE | $299,198 | $705,469 | $727,344 |
| Accumulated Depreciation | $-24,987 | $-194,518 | $-172,643 |
| Gross PPE | $324,185 | $899,987 | $899,987 |
| Other Properties | $299,198 | - | - |
| Machinery Furniture Equipment | $24,987 | $24,987 | $24,987 |
| Buildings And Improvements | $0 | $875,000 | $875,000 |
| Properties | $0 | $0 | $0 |
| Finished Goods | $68,517 | $62,061 | $218,510 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-1,567,098 | $-773,337 | $-1,193,688 |
| Operating Activities | |||
| Operating Cash Flow | $-1,417,393 | $-773,337 | $-1,193,688 |
| Cash Flow From Continuing Operating Activities | $-1,417,393 | $-773,337 | $-1,193,688 |
| Operating Gains Losses | $-725,850 | $1,073,900 | $1,365,602 |
| Investing Activities | |||
| Capital Expenditure | $-149,705 | - | - |
| Investing Cash Flow | $1,744,883 | $0 | - |
| Cash Flow From Continuing Investing Activities | $1,744,883 | $0 | - |
| Financing Activities | |||
| Issuance Of Capital Stock | $0 | $42,766 | $0 |
| Financing Cash Flow | $-608,211 | $758,592 | $1,311,945 |
| Cash Flow From Continuing Financing Activities | $-608,211 | $758,592 | $1,311,945 |
| Net Common Stock Issuance | $0 | $42,766 | $0 |
| Common Stock Issuance | $0 | $42,766 | $0 |
| Other | |||
| Repayment Of Debt | $-608,386 | $-829,314 | $-198,055 |
| Issuance Of Debt | $0 | $1,545,140 | $1,510,000 |
| Interest Paid Supplemental Data | $40,241 | $103,819 | $154,081 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 |
| End Cash Position | $87,704 | $368,425 | $383,170 |
| Beginning Cash Position | $368,425 | $383,170 | $264,913 |
| Changes In Cash | $-280,721 | $-14,745 | $118,257 |
| Proceeds From Stock Option Exercised | $175 | $0 | - |
| Net Issuance Payments Of Debt | $-608,386 | $715,826 | $1,311,945 |
| Net Long Term Debt Issuance | $-608,386 | $715,826 | $1,311,945 |
| Long Term Debt Payments | $-608,386 | $-829,314 | $-198,055 |
| Long Term Debt Issuance | $0 | $1,545,140 | $1,510,000 |
| Net PPE Purchase And Sale | $1,744,883 | $0 | - |
| Sale Of PPE | $1,894,588 | $0 | - |
| Purchase Of PPE | $-149,705 | $0 | - |
| Change In Working Capital | $567,312 | $505,524 | $232,048 |
| Change In Other Working Capital | $-19,387 | $217,588 | $-25,812 |
| Change In Other Current Liabilities | $-18,014 | $1,067 | $-6,436 |
| Change In Payables And Accrued Expense | $688,662 | $274,649 | $153,026 |
| Change In Accrued Expense | $725,461 | $196,340 | $205,982 |
| Change In Payable | $-36,799 | $78,309 | $-52,956 |
| Change In Account Payable | $-27,263 | $51,959 | $-40,529 |
| Change In Prepaid Assets | $-80,693 | $-169,870 | $285,860 |
| Change In Inventory | $-6,456 | $156,449 | $-139,798 |
| Change In Receivables | $3,200 | $25,641 | $-17,391 |
| Changes In Account Receivables | $3,200 | $25,641 | $-17,391 |
| Other Non Cash Items | $639,341 | $584,261 | $3,036,792 |
| Stock Based Compensation | $715,000 | $509,603 | $2,630,144 |
| Provisionand Write Offof Assets | $1,845 | $0 | $0 |
| Depreciation Amortization Depletion | $26,205 | $21,875 | $21,875 |
| Depreciation And Amortization | $26,205 | $21,875 | $21,875 |
| Depreciation | $26,205 | $21,875 | - |
| Gain Loss On Investment Securities | $476,207 | - | $1,415,685 |
| Gain Loss On Sale Of PPE | $-1,193,676 | $0 | - |
| Net Income From Continuing Operations | $-2,641,246 | $-3,468,500 | $-8,480,149 |
| Change In Other Current Assets | - | $0 | $-17,401 |
| Net Short Term Debt Issuance | - | - | $0 |
Fetched: 2026-02-02